SBI Securities’s GlucoTrack GCTK Stock Holding History

SBI Securities’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16	Buy	10 +9	+900%	+$43	﹤0.01%	3951
2026 Q2	$3	Hold	1	–	–	﹤0.01%	4019
2026 Q1	$6	Hold	1	–	–	﹤0.01%	3895
2025 Q4	$35	Hold	1	–	–	﹤0.01%	3650
2025 Q3	$59	Hold	1	–	–	﹤0.01%	3665
2025 Q2	$60	Buy	+1	New	+$132	﹤0.01%	3680
2025 Q1	–	Hold	0	–	–	–	4063
2024 Q4	–	Hold	0	–	–	–	4036

SBI Securities's GCTK Position: Q3 2026 in Review

SBI Securities increased its GlucoTrack (GCTK) stake by 900% in Q3 2026, buying an estimated $43 and bringing the position to 10 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

SBI Securities first reported a position in GCTK in Q2 2025 and has held it in 6 quarters since. The position peaked at $60 in Q2 2025. 1 fund tracked by Wall St. Rank holds GCTK as of Q3 2026.

SBI Securities held 10 shares of GlucoTrack worth $16 as of Q3 2026.
SBI Securities bought 9 GlucoTrack shares in Q3 2026, an estimated $43.
GlucoTrack made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3951 holding.
SBI Securities first reported a position in GlucoTrack in Q2 2025 and has held it in 6 quarters since.
SBI Securities's GlucoTrack position peaked at $60 in Q2 2025.
1 fund tracked by Wall St. Rank held GlucoTrack as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.